Gerrit Hagens

CEO BioXpress Therapeutics

Geneva, Geneva, Switzerland

About

R&D biologics and manufacturing process development, CAR T-cell therapies, Stem cell production

Experience

  • Member Board of Directors at ImmunSkills SA
    Dec 2022 - Present · 3 yrs 8 mos

  • Member Board of Directors at CEIDOS
    Nov 2021 - Present · 4 yrs 9 mos

  • Chief Executive Officer at BioXpress Therapeutics
    Jan 2025 - Present · 1 yr 7 mos

    Development of biosimilar monoclonal antibodies

  • Co-Founder at NatiMab Therapeutics
    2008 - Present · 18 yrs 7 mos

    Development of therapeutic and diagnostic monoclonal antibodies

  • Senior Partner, Head of Biotechnology Department at RidePharm
    Jan 2005 - Present · 21 yrs 7 mos

    Consulting Biotech and Pharma companies concerning all aspects from R&D to marketing